d-alpha tocopherol has been researched along with lisinopril in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ansell, H; Patel, VB; Preedy, VR; Reeves, J; Richardson, PJ; Siddiq, T; Wassif, WS; Why, HJ | 1 |
O'Valle, F; Pérez-Caballero, C; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Ginés, JA | 1 |
Ahmed, S; MacNee, W; Mantle, D; Patel, VB; Preedy, VR; Rahman, I; Richardson, PJ; Wassif, WS; Why, HJ | 1 |
Arya, DS; Dinda, A; Gupta, SK; Mohanty, IR | 1 |
Akintunde, DG; Akintunde, JK; Bolarin, OE | 1 |
1 review(s) available for d-alpha tocopherol and lisinopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for d-alpha tocopherol and lisinopril
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antioxidant status in hypertension and effects of angiotensin converting enzyme inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Pressure; Cholesterol; Hypertension; Lisinopril; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vitamin E | 1995 |
Captopril inhibits pp60(c-src) tyrosine phosphorylation in cultured human mesangial cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cell Division; Cells, Cultured; Glomerular Mesangium; Humans; Lisinopril; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Vitamin E | 1997 |
Effects of lisinopril and amlodipine on antioxidant status in experimental hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Urea Nitrogen; Calcium Channel Blockers; Cholesterol; Hypertension; Lisinopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serum Albumin; Triglycerides; Vitamin A; Vitamin E | 2000 |
Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arterial Pressure; Blood Pressure; Disease Models, Animal; Heart Rate; Lisinopril; Male; Myocardial Reperfusion Injury; Protective Agents; Rats; Rats, Wistar; Ventricular Function, Left; Vitamin E | 2013 |
Garlic capsule and selenium-vitamins ACE combination therapy modulate key antioxidant proteins and cellular adenosine triphosphate in lisinopril-induced lung damage in rats.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Ascorbic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Garlic; Lipid Peroxidation; Lisinopril; Lung Diseases; Male; Rats; Rats, Wistar; Respiratory Mucosa; Selenium; Vitamin A; Vitamin E; Vitamins | 2016 |